Pengetahuan, Sikap, dan Kesediaan untuk Menerima Vaksin Booster COVID-19 pada Masyarakat di Jawa Timur
Downloads
Berbagai cara dilakukan untuk memutus rantai penyebaran COVID-19. Di Indonesia, pemerintah telah melakukan berbagai upaya yang salah satunya adalah program vaksinasi. Saat ini, pemerintah juga mengeluarkan Surat Edaran tentang Vaksinasi COVID-19 Dosis Ketiga (booster) untuk meningkatkan proteksi individu. Penelitian ini bertujuan untuk mengetahui tingkat pengetahuan, sikap, dan kesediaan masyarakat di Jawa Timur untuk menerima vaksin booster COVID-19. Penelitian ini merupakan studi observasional dengan pendekatan cross-sectional menggunakan instrumen berupa kuesioner. Responden adalah masyarakat Kota Surabaya yang berusia 18-64 tahun yang didapatkan secara accidental sampling. Analisis statistik dilakukan dengan metode deskriptif. Sebanyak 119 masyarakat Jawa Timur berpartisipasi pada penelitian ini. Didapatkan tingkat pengetahuan sebanyak 105 (88,2%) responden termasuk dalam kategori cukup dan 14 (11,8%) responden termasuk dalam kategori baik. Pada bagian sikap responden menunjukkan sejumlah 26 (21,8%) termasuk kategori netral dan 78,2% (n=93) termasuk kategori positif. Penerimaan vaksin booster COVID-19, jumlah responden yang sudah melakukan adalah sejumlah 80(67,2%) dan yang bersedia secepatnya menerima vaksin ini sebanyak 21 (17,2%). Disisi lain, terdapat masyarakat yang tidak bersedia menerima vaksin booster COVID-19 sebanyak 15 (12,6%) dikarenakan masih mempunyai keraguan terhadap efektivitas, takut akan efek samping, dan merasa dosis yang diterima sudah cukup untuk melindungi dari COVID-19. Dari penelitian ini dapat disimpulkan bahwa sebagian besar masyarakat di Jawa Timur telah menunjukkan pengetahuan, sikap, dan penerimaan yang tinggi terhadap vaksin booster COVID-19.
Abdelhafiz, A.S., Mohammed, Z., Ibrahim, M., Ziady, H., Alorabi, M., Ayyad, M., Sultan, E. A. (2020) ‘Knowledge, perceptions, and attitude of egyptians towards the novel coronavirus disease (COVID-19)', Journal of Community Health, 45(5), pp. 881–890.doi: 10.1007/s10900-020-00827-7.
Abraham, E.P. (1963) ‘The antibiotics', Comprehensive Biochemistry, 11(4), pp. 181–224. doi: 10.1016/B978-1-4831-9711-1.50022-3.
Al-Mohaithef, M., and Padhi. B. K. (2020) ‘Determinants of COVID-19 vaccine acceptance in Saudi Arabia: a web-based national survey', Journal of multidisciplinary healthcare, 13(11), p. 1657-1663. doi: 10.2147/JMDH.S276771
Babicki, M. and Mastalerz-Migas, A. (2022) ‘Attitudes
of Poles towards the COVID-19 Vaccine Booster Dose: An Online Survey in Poland', Vaccines, 10(1), pp. 1-10 doi: 10.3390/vaccines10010068.
Bar-On, Y.M., Goldberg, Y., Mandel, M., Bodenheimer, O., Freedman, L., Kalkstein, N., Mizrahi, B., Preis, S. A., Ash, N., Milo, R., Huppert, A. (2021) ‘Protection of BNT162b2 vaccine booster against COVID-19 in Israel', New England Journal of Medicine, 385(15), pp. 1393–1400. doi: 10.1056/nejmoa2114255.
Biswas, M. R., Alzubaidi, M., Shah, U., Alrazaq, A., Shah, Z. (2021) ‘A scoping review to find out Worldwide COVID-19 vaccine hesitancy and its underlying determinants', Vaccines, 9(11), p. 1243. doi: 10.3390/vaccines9111243
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., Li, X., and Xia, J. (2020) ‘A Trial of lopinavir–ritonavir in adults Hospitalized with severe Covid-19', New England Journal of Medicine, 382(19), pp. 1787–1799. doi: 10.1056/nejmoa2001282.
Cerda and Garcia (2021) ‘Hesitation and refusal factors
in individuals' decision-making processes regarding a coronavirus disease 2019 vaccination', Frontiers in public health, 9.
Chew, N.W.S., Lee, G., Tan, B., Jing, M., Goh, Y., Ngiam, N., Yeo, L., Ahmad, A., Khan, F., Shanmugam, G., Sharma, A., Chen, J., Ying, A., Teoh, H., Tsivgoulis, G., Ho, R., and Sharma, V. K. (2020) ‘A multinational, multicentre study on the psychological outcomes and associated physical symptoms amongst healthcare workers during COVID-19 outbreak.', Brain, Behavior, and Immunity, 88(5), pp. 559-565. doi: 10.1016/j.bbi.2020.04.049
Elhadi, M., Alsoufi, A., Alhadi, A., Hmeida, A., Alshareea, E., Dokali, M., Abodabos, S., Alsadiq, O., Abdelkabir, M., Ashini, A., Algathafi, K., Abdulwahed, E., Jaafari, A., Khaled, A., Zaid, A., and Msherghi, A. (2021) ‘Knowledge, attitude, and acceptance of healthcare workers and the public regarding the COVID-19 vaccine: A cross-sectional study', BMC Public Health, 21(1), pp. 1–21. doi: 10.1186/s12889-021-10987-3.
Islam, M.S., Siddique, A. B., Akter, R., Tasnim, R., Sujan, M. S., Ward, P., and Sikder, M. T.(2021) ‘Pengetahuan, sikap, dan persepsi terhadap vaksinasi COVID-19: Survei komunitas lintas seksi di Bangladesh', BMC Public Health, 21(1), pp. 1–11. doi: 10.1186/s12889-021-11880-9.
Kemenkes RI. (2022) Vaksin, Vaksin Dashboard. Available at: https://vaksin.kemkes.go.id/#/scprovinsi.
Litbangkes (2021) Buku Saku Hasil Studi Status Gizi
Indonesia (SSGI). Jakarta: Badan Litbangkes Kementrian Kesehatan RI.
Machida, M., Nakamaru, I., Kojima, T., Saito, R., Nakaya, T., Hanibuchi, T., Takamiya, T., Odagiri, Y., Fukushima, N., Kikuchi, H., Amagasa, S., Watanabe, H., and Inoue, S. (2021) ‘Acceptance of a covid-19 vaccine in japan during the covid-19 pandemic', Vaccines, 9(3), pp. 1–11. doi: 10.3390/vaccines9030210.
Shahwan, M., Suliman, A., Jairoun, A., Alkoujah, S., Alhemyari, S., Altamimi, S., Godma, B., and Mothana, R. (2022) ‘Prevalence, knowledge and potential determinants of COVID-19 vaccine acceptability among University Students in the United Arab Emirates: Findings and Implications', Journal of multidisciplinary healthcare, 15(1), p. 81-92. doi: 10.2147/JMDH.S341700.
Wald, A. (2022) ‘Booster vaccination to reduce SARS-
CoV-2 transmission and infection', JAMA - Journal of the American Medical Association. American Medical Association, pp. 327–328. doi: 10.1001/jama.2021.23726.
Walkowiak, M. (2021) ‘Predictors of COVID-19 vaccination campaign success: lessons learnt from the pandemic so far. a case study from Poland.', Vaccines, 9(10), p. 1153. doi: 10.3390/vaccines9101153.
WHO (2022) ‘Coronavirus', Coronavirus [Preprint]. Available at: https://www.who.int/health-topics/coronavirus.
Wiysonge, C. S., Ndwandwe, D., Ryan, J., Jaca, A., Batoure, O., Anya, B. M., and Cooper, S. (2022) ‘Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?', Human vaccines & immunotherapeutics, 18(1), pp. 1–3. doi: 10.1080/21645515.2021.1893062.
Copyright (c) 2023 Jurnal Farmasi Komunitas
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
In order to be accepted and published by JFK, author(s) submitting the article manuscript should complete all the review stages. By submitting the manuscript, the author(s) agreed to these following terms:
1. Copyright of the article is transferred to the journal (JFK), by the knowledge of the author, whilst the moral right of the publication belongs to the author. The intended copyright includes the rights to publish articles in various forms (including reprints). JFK maintain the publishing rights to the published articles.
2. The formal legal aspect of journal publication accessibility refers to the Creative Commons Attribution-Non-Commercial-Share Alike (CC BY-NC-SA), which implies that the publication can be used for non-commercial purposes in its original form.
3. Every publication (print/electronic) is open access for educational, research, and library purposes. In addition to the objectives mentioned above, the editorial board is not responsible for copyright infringement
The Copyright Transfer Agreement Form can be downloaded ON THIS FORM.
Jurnal Farmasi Komunitas (JFK) by Unair is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
